Sponsor or institution
Clinical trials and research at GigaGen, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by GigaGen, Inc. that are recruiting, at sites in 5 countries (most in United States (2), Australia (1), Hong Kong (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 5Countries
All recruiting trials (2)
-
GIGA-2339: safety and drug behavior testing in people with chronic hepatitis B
This trial tests single and multiple IV doses of GIGA-2339 versus placebo to see if they are safe and well tolerated in adults with chronic hepatitis B.
-
Testing GIGA-564 for advanced or metastatic solid tumors
This study is testing a new treatment called GIGA-564 to see if it is safe and how well it works for people with advanced solid tumors who can't use standard treatments.
Quick answers
How many clinical trials run by GigaGen, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (2 trials), Australia (1 trial), Hong Kong (1 trial), South Korea (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.